Crescita Therapeutics (TSE:CTX) Trading 5.4% Higher – What’s Next?

Crescita Therapeutics Inc. (TSE:CTX) shares shot up 5.4% during trading on Monday . The company traded as high as C$0.60 and last traded at C$0.59. 20,875 shares changed hands during trading, an increase of 102% from the average session volume of 10,325 shares. The stock had previously closed at C$0.56.

Crescita Therapeutics Trading Up 5.4 %

The firm has a market cap of C$10.86 million, a P/E ratio of -4.01 and a beta of 1.69. The company’s 50 day moving average is C$0.56 and its two-hundred day moving average is C$0.58. The company has a debt-to-equity ratio of 5.77, a current ratio of 2.70 and a quick ratio of 2.29.

Insiders Place Their Bets

In other Crescita Therapeutics news, Director Jose Darocha acquired 86,000 shares of Crescita Therapeutics stock in a transaction dated Friday, December 27th. The stock was bought at an average cost of C$0.60 per share, with a total value of C$51,436.60. Corporate insiders own 10.87% of the company’s stock.

About Crescita Therapeutics

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.